Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Monor – page 14

1 099 clinical trials in Monor, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Monor at a glance
1 099
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 099 trials in Monor

Open in trial search

Phase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Glatiramer Acetate
  • Sponsor:Genmab A/S

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

A study of YL201 and atezolizumab for patients with advanced solid tumors

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Medilink Therapeutics (Suzhou) Co. Ltd.

Pain+3

Recruiting

A study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ibuprofen
  • Sponsor:Aft Pharmaceuticals Limited

A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Boehringer Ingelheim International GmbH

A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-142
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Alvotech Swiss AG

Hidradenitis

Recruiting

A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:SAR445399
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Monor

What the registry says about research in the country

01 Asthma Research

Innovative trials focusing on uncontrolled moderate to severe asthma, evaluating new therapeutic approaches for better disease management. Studies aim to prevent lung function decline and reduce exacerbations.

  • Lung Function Preservation
  • Exacerbation Prevention
  • Maintenance Therapy Enhancement

Research includes evaluation of novel compounds and established treatments as add-on therapies to existing maintenance medications.

02 COPD Management

Comprehensive research into Chronic Obstructive Pulmonary Disease treatments, investigating both triple therapy combinations and novel biological treatments for moderate to severe cases.

  • Triple Therapy Optimization
  • Long-term Safety Studies
  • Exacerbation Reduction

Studies focus on improving cardiopulmonary outcomes and evaluating long-term treatment effectiveness in COPD patients.

03 Respiratory Therapeutics

Advanced clinical research examining innovative respiratory medications and their combinations, with particular attention to treating both asthma and COPD through various delivery systems.

  • Combined Therapy Approaches
  • Inhaler Technology
  • Disease Control Optimization

Investigations include both established treatment combinations and novel therapeutic agents for respiratory conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.